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Abstract
Background: Although many years of genetic epidemiological studies have demonstrated that
genetics plays a significant role in determining smoking behavior, little information is available on
genomic loci or genes affecting nicotine dependence. Several susceptibility chromosomal regions
for nicotine dependence have been reported, but few have received independent confirmation. To
identify susceptibility loci for nicotine dependence, 313 extended pedigrees selected from the
Framingham Heart Study population were analyzed by both the GENEHUNTER and S.A.G.E.
programs.
Results: After performing linkage analyses on the 313 extended Framingham Heart Study families,
the EM Haseman-Elston method implemented in GENEHUNTER provided evidence for significant
linkage of smoking rate to chromosome 11 and suggestive linkage to chromosomes 9, 14, and 17.
Multipoint sib-pair regression analysis using the SIBPAL program of S.A.G.E. on 1389 sib pairs that
were split from the 313 extended families identified suggestive linkage of smoking rate to
chromosomes 4, 7, and 17. Of these identified positive regions for nicotine dependence, loci on
chromosomes 7, 11, and 17 were identified by both GENEHUNTER and S.A.G.E. programs.
Conclusion: Our genome-wide scan results on the Framingham Heart Study data provide
evidence for significant linkage of smoking rate to chromosome 11 and suggestive linkage to
chromosomes 4, 7, 9, 14, and 17. These findings suggest that some of these regions may harbor
susceptibility loci for nicotine dependence, and warrant further investigation in this and other
populations.
Background
Over the last several decades, a number of twin studies
throughout the world have yielded results consistent with
the overall conclusion that both genetic and environmen-
tal factors contribute to the risk of becoming a long-term
smoker (for reviews, see [1,2]). After performing a meta-
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related behaviors in the literature, we found that genetic
factors contribute approximately 50% to smoking initia-
tion and 59% to smoking persistence [3].
Although the twin studies suggest moderate genetic influ-
ences on nicotine dependence, little information is pro-
vided about the chromosomal locations harboring
susceptibility loci/genes for nicotine dependence. Link-
age-based genome-wide scans for smoking behavior have
been reported by Straub et al. [4] on the Christchurch
sample of New Zealand (130 families with 343 genotyped
individuals) and the Richmond sample of Virginia (91
families with 264 genotyped individuals), and by Duggi-
rala et al. [5] and Bergen et al. [6] on the Collaborative
Study on the Genetics of Alcoholism data (COGA; 105
families with 987 genotyped individuals). However, only
a few susceptibility regions for nicotine dependence from
one study were replicated in another study.
Generally speaking, there are two approaches available to
address this problem of identifying susceptibility loci for
nicotine dependence and other complex disorders. The
first approach is to repeat and extend these genome-wide
linkage analyses in different populations; the second is to
use higher marker densities for association genome scan-
ning studies. Based on the availability of information on
smoking phenotype in the Framingham Heart Study pop-
ulation, we adopted the first genome-wide scan approach
to identify susceptibility loci for nicotine dependence in
the present study.
Methods
Data from the Framingham Heart Study along with clini-
cal exam information from 1948 through 1988 for the
original cohort and from 1971 through 1991 for the off-
spring cohort were provided through Genetics Analysis
Workshop 13 (GAW13). On the basis of number of smok-
ers present at each exam, the consistency of the clinical
data and interviewing time between the two cohorts, and
the potential environmental effect on smoking phenotype
included in the Framingham Heart Study data, Exam 12
from 1970 for the original cohort and Exam 1 from 1971
for the offspring cohort were selected and used in this
study.
From the 330 extended families of the Framingham Heart
Study, 313 were chosen in which there was at least one
smoker present in the data from 1970–1971. Table 1
shows some of the characteristics of the sample used in
the current study. The smoking rate (SR) phenotype of
each individual reported in the study was based on self-
reported average number of cigarettes smoked per day
during 1970–1971. Information on smoking rate was
available for 2493 of the 4522 members distributed across
the 313 families. Of these 2493 subjects, 1636 were geno-
typed for 401 markers at an average spacing of 7.5 cM
between markers. For individuals who reported non-
smoking, we considered their phenotype as 'zero' and
included them in the linkage analysis. On the other hand,
we considered the phenotypes of individuals who did not
report their smoking status during the survey as
'unknown' and excluded them from the analysis. Skew-
ness and kurtosis for the self-reported average number of
cigarettes smoked per day were 1.38 and 5.11, respec-
tively. To minimize the impact of skewness on linkage
analysis results, we transformed the non-zero smoking
rates to a natural log-scale prior to linkage analysis (called
log-transformed SR). Skewness and kurtosis for this log-
transformed smoking rate (including the zeros) became
0.31 and 1.30, respectively. Additionally, we generated a
third data set for smoking rate (called categorized SR) in
which individuals who smoked 0, 1–5, 6–15, 16–25, 26–
35, and greater than 35 cigarettes per day were assigned
the values 0, 1, 2, 3, 4, and 5, respectively. Skewness and
kurtosis for the categorized SR were 0.58 and 1.88,
respectively.
Two linkage analysis programs (SIBPAL in S.A.G.E. v. 4.2
and GENEHUNTER v. 2.1) were used in the study. For the
EM (expectation maximization) Haseman-Elston quanti-
tative trait locus (QTL) regression method implemented
in GENEHUNTER, we analyzed both log-transformed and
categorized SR data sets. A detail description on the
method can be found in Kruglyak et al. [7] and Kruglyak
and Lander [8]. In SIBPAL, default options were used for
all parameters in the trait regression method except that
the options w3 (the weighted combination of squared
trait difference and squared mean-corrected trait sum
adjusting for the non-independence of sib pairs) and w4
(the non-independence of squared trait sums and differ-
ences) were examined [9]. Both options yielded essen-
tially the same results on three data sets (i.e., SR, log-
transformed SR and categorized SR). Sex and age were
included as covariates for all analyses reported in this
communication. The S-PLUS 6.1 and SAS 8.2 packages
were used to prepare the data in the required format and
to analyze the data generated from the linkage analysis
programs.
Results
To maximally utilize the phenotypic information from
the Framingham Heart Study data, we searched clinical
records regarding smoking status of each subject from
1948 to 1988 for the original cohort, and from 1971 to
1989 for the offspring cohort. It appears that data from
1970 for the original cohort and from 1971 for the off-
spring cohort were more complete and contained signifi-
cantly more smokers relative to other time points (i.e.,
exams) for both cohorts. As shown in Table 1, 1228 smok-Page 2 of 5
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smoking rate of 23.51 and 17.95 cigarettes for men and
women, respectively. The average age of smokers included
in this study was 38.7 ± 13.4 for male and 39.73 ± 13.8 for
female subjects.
After performing linkage analysis on both log-trans-
formed and categorized smoking rate data sets with the
EM Haseman-Elston QTL regression method imple-
mented in GENEHUNTER, we found evidence for signifi-
cant linkage of smoking rate to chromosome 11 in both
the log-transformed (p = 0.000018) and the categorized
SR data sets (p = 0.000001), based on the threshold sug-
gested by Nyholt [10]. We also found evidence for sugges-
tive linkage of smoking rate to chromosomes 9, 14, and
17 (p < 0.0017; [10]). Further, we found several regions
located on chromosomes 7, 15, and 20 to be of potential
interest at a significance level of p < 0.01 (Table 2). To con-
firm these findings, we analyzed the original and trans-
formed SR data sets using the SIBPAL program in S.A.G.E.
(v. 4.2) with the option of splitting these extended fami-
lies into nuclear families, which yielded 1389 sib pairs.
Three loci for which SIBPAL provided evidence for sugges-
tive linkage were mapped onto chromosomes 4, 7, and
17. In addition, we found six more loci of potential inter-
est at a significant level of 0.01 (Table 3).
Discussion
In this study, by using the EM Haseman-Elston QTL
regression method implemented in GENEHUNTER and
the SIBPAL program of S.A.G.E., we obtained evidence for
significant linkage of smoking rate to chromosome 11
and suggestive linkage to chromosomes 4, 7, 9, 14, and
17. Additionally, our results suggest that the genomic
regions mapped on chromosomes 1, 6, 12, 15, 20, and 21
are of potential interest to harbor susceptibility genes for
nicotine dependence at a significance level of 0.01. Of
these loci, three loci on chromosomes 7, 11, and 17 were
identified by both linkage analysis methods.
Although our mapping results provided weak evidence for
linkage of smoking rate to chromosome 20 (p = 0.0063;
Table 1: Characteristics of pedigrees to map susceptibility loci for smoking rate.
Category Mean ± SEM (Range) Sample SizeA
No. of subjects per pedigree 8.25 ± 0.31 (3–53) 313
No. of smokers per pedigree 3.92 ± 0.16 (1–25) 313
Age of subjects 43.76 ± .34 (9–83) 2583
Male subjects 42.92 ± 0.49 (11–82) 1242
Female subjects 44.54 ± 0.46 (9–83) 1341
Age of smokers 39.23 ± 0.39 (13–80) 1228
Male smokers 38.73 ± 0.54 (15–79) 614
Female smokers 39.73 ± 0.56 (13–80) 614
Self-reported cigarettes per day, 1970–1971 20.73 ± 0.35 (1–90) 1228
Male smokers 23.51 ± 0.53 (1–90) 614
Female smokers 17.95 ± 0.43 (1–60) 614
AThe unit of measurement is number of pedigrees for the first two and number of individual subjects for all other rows.
Table 2: The p-value for genomic locations linked to categorized and log-transformed SR across the human genome with a p-value < 
0.01 for at least one transformed data set, as detected by the EM-Haseman-Elston method in GENEHUNTER.
Chromosome Locus Log-transformed SR (peak 
position)
Categorized SR (peak 
position)
7 GATA31A10 & GATA24D12 0.0087 (64) >0.05 (64)
9 183xh10 & ATA18A07 0.0039 (106) 0.00057B (106)
11 GGAA5C04 & GATA90D07 0.000018A (70) 0.000001A (70)
14 GATA51E09 & GGAA21G11 0.0011B (111) >0.05 (111)
15 GATA73F01 & GATA27A03 0.0037 (127) 0.0247 (127)
17 ATA78D02 & GATA185H04 0.0043 (37) 0.00075B (41)
20 GATA47F05 & 321xd1 0.0139 (82) 0.0063 (82)
ASignificant linkage and B Suggestive linkage according to the threshold suggested by Nyholt [10].Page 3 of 5
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same Framingham Heart Study data, two other research
groups [11,12] independently reported weak linkage of
the maximum number of cigarettes smoked per day across
the first four exams or across all exams of the original and
offspring cohorts onto the same region of chromosome
20 identified in this study. To our knowledge, no previous
studies in the literature have identified linkage or associa-
tion with this region on chromosome 20. Therefore, it will
be of interest to confirm this finding in other studies. The
reason that we achieved lower p-values for most regions
reported in our study than other GAW13 analyses evaluat-
ing smoking as the phenotype may due to how the data
measuring smoking phenotype were selected from the
Framingham Heart Study data. As indicated earlier, we
only used the smoking information obtained from the
exam conducted during 1970–1971, instead of using the
maximum number of cigarettes smoked per day across
multiple exams over many years. Epidemiological studies
have indicated that there has been a steady and dramatic
decline of 40% in the prevalence of cigarette smoking by
people 18 years or older in the US from 1965 to 1990
[13]. This was also true in the Framingham Heart Study
data (data not shown). Therefore, using smoking infor-
mation obtained from multiple exams over a long period
of time may affect estimation of the genetic and environ-
mental parameters, and thus eventually the linkage analy-
sis results. Nicotine dependence is a complex trait with
strong genetic and environmental influences. Many years
of genetic epidemiological studies have documented that
smoking behavior is determined by multiple genetic and
environmental factors, and interaction among these fac-
tors. Strong evidence for linkage of smoking behavior to
chromosome 5q has been reported from an analysis of the
COGA data [5]. The linkage to smoking behavior on chro-
mosome 5 was also reported by another study with a dif-
ferent linkage analysis method but at a marginal level of
significance [6]. In another independent study, Straub et
al. [4] identified several possible regions for nicotine
dependence on chromosomes 2, 4, 10, 16, 17 and 18 in
the Christchurch sample of New Zealand but failed to
confirm these regions in the Richmond sample of Vir-
ginia. This was probably due to insufficient statistical
power as a result of the small sample size of the Richmond
cohort (91 families with 264 genotyped individuals).
Compared with the research described above, a much
larger sample size was used in the present study, which
may contribute partially to the significant p-values
obtained in this study.
There are limitations to this study. For example, we used
the number of cigarettes smoked per day as an indirect
measure of nicotine dependence without consideration of
which cigarette brand each smoker smoked. It is known
that there exists a significant variation in nicotine concen-
tration present in each cigarette brand. Therefore, the phe-
notype of smoking rate used here may represent only a
very rough measure of nicotine dependence. Given the
objective of this study and the limitation of the data set
used in the analysis, we did not, nor were we able to, dis-
tinguish individuals in the non-smoking group who had
been passively exposed to smoking (i.e., through second-
hand smoke) from those who were never exposed to
nicotine. As documented earlier, the transformed smok-
ing phenotype still deviated slightly from a normal distri-
bution; however, we do not feel that such remaining
kurtosis would have a large effect on the linkage results
reported herein, because only model-free methods were
used in the analysis and they tend to be more robust to the
presence of non-normality in the data. Also, the partici-
pants in the Framingham Heart Study are predominantly
Caucasian Americans. Accordingly, it is of interest to
Table 3: The p-value for genomic locations linked to smoking rate (SR), categorized and log-transformed SR across the human genome 
with a p-value for at least one transformed data set, as detected by SIBPAL program.
Chromosome Locus SR (peak position) Log-transformed SR 
(peak position)
Categorized SR (peak 
position)
1 GGAA5F09 >0.05 (188) 0.0045 (188) 0.0347 (188)
4 GATA42H02 & 165xc11 0.0017A (217) 0.0042 (203) 0.0036 (205)
6 SE30 0.0030 (10) >0.05 (10) >0.05 (10)
7 GATA31A10 >0.05 (63) 0.0016A (63) 0.0044 (63)
11 GGAA5C04 & 
GATA90D07
>0.05 (68) 0.0084 (68) 0.0097 (72)
12 GATA3F02 0.0021 (88) >0.05 (88) >0.05 (88)
17 ATA78D02 & 
GATA185H04
0.0004A (45) 0.0106 (45) 0.0225 (45)
17 ATC6A06 & GATA49C09 0.0095 (87) >0.05 (87) >0.05 (87)
21 GATA188F04 0.0096 (44) >0.05 (44) >0.05 (44)
ASuggestive linkage according to the threshold suggested by Nyholt [10].Page 4 of 5
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know whether we can repeat these findings in other ethnic
populations.
Conclusions
The 313 extended Framingham Heart Study families were
analyzed to identify susceptibility loci for smoking rate by
the Haseman-Elston regression methods implemented in
GENEHUNTER and the SIBPAL program of S.A.G.E. Our
genome-wide scan results provided evidence for signifi-
cant linkage of smoking rate to chromosome 11 and sug-
gestive linkage to chromosomes 4, 7, 9, 14, and 17.
Additionally, we found several regions located on chro-
mosomes 1, 6, 12, 15, 20, and 21 are potentially of inter-
est with a significance level of <0.01. Interestingly, the
genomic regions on chromosomes 7, 11, and 17 were
identified by both the linkage methods. To our knowl-
edge, most of the susceptibility regions for smoking rate
identified in this study have not been reported previously
and thus replication of these findings is an important next
step.
Acknowledgments
This work was partially supported by NIH grants DA-12844 to MDL and 
GM-28356 to RCE. Some results of this paper were obtained by using the 
program package S.A.G.E., which is supported by a U. S. Public Health Serv-
ice Resource Grant (RR03655) from the National Center for Research 
Resources. The Framingham Heart Study is conducted and supported by 
the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with 
Boston University. This manuscript was not prepared in collaboration with 
investigators of the Framingham Heart Study and does not necessarily 
reflect the opinions or reviews of the Framingham Heart Study, Boston 
University, or NHLBI.
References
1. Hughes JR: Genetics of smoking: a brief review. Behav Ther 1986,
17:335-345.
2. Sullivan PF, Kendler KS: The genetic epidemiology of smoking.
Nicotine Tobacco Res 1999, 1:S51-S57.
3. Li MD, Cheng R, Ma JZ, Swan GE: A meta-analysis of estimated
genetic and environmental effects on smoking behavior in
male and female adult twins. Addiction 2003, 98:23-31.
4. Straub RE, Sullivan PF, Ma Y, Myakishev MV, Harris-Kerr C, Wormley
B, Kadambi B, Sadek H, Silverman MA, Webb BT, Neale MC, Bulik
CM, Joyce PR, Kendler KS: Susceptibility genes for nicotine
dependence: a genome scan and followup in an independent
sample suggest that regions on chromosomes 2, 4, 10, 16, 17
and 18 merit further study. Mol Psychiatry 1999, 4:129-144.
5. Duggirala R, Almasy L, Blangero J: Smoking behavior is under the
influence of a major quantitative trait locus on human chro-
mosome 5Q. Genet Epidemiol 1999, 17(suppl 1):S139-S144.
6. Bergen AW, Korczak JF, Weissbecker KA, Goldstein AM: A
genome-wide search for loci contributing to smoking and
alcoholism. Genet Epidemiol 1999, 17(suppl 1):S55-S60.
7. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES: Parametric and
nonparametric linkage analysis: a unified multipoint
approach. Am J Hum Genet 1996, 58:1347-1363.
8. Kruglyak L, Lander ES: Complete multipoint sib-pair analysis of
qualitative and quantitative traits. Am J Hum Genet 1995,
57:439-454.
9. Statistical Solutions: S.A.G.E.: Statistical Analysis for Genetic
Epidemiology, Release 4.2. Cork, Ireland 2002.
10. Nyholt DR: All LODs are not created equal. Am J Hum Genet
2000, 67:282-288.
11. Bergen AW, Yang R, Bai Y, Beerman M, Goldstein AM, Goldin LR:
Genomic regions linked to alcohol consumption in the Fram-
ingham Heart Study. BMC Genetics 2003, 4(suppl 1):S101.
12. Goode EL, Badzioch MD, Kim H, Gagnon F, Rozek LS, Edwards KL,
Jarvik GP: Multiple genome-wide analysis of smoking behavior
in the Framingham Heart Study. BMC Genetics 2003, 4(suppl
1):S102.
13. Giovino GA, Henningfield JE, Tomar SL, Escobedo LG, Slade J: Epide-
miology of tobacco use and dependence. Epidemiol Rev 1995,
17:48-65.Page 5 of 5
(page number not for citation purposes)
